Skip to content

Transverse Colostomy for Refractory Hemorrhagic Chronic Radiation Proctitis: a Prospective Cohort Study

Transverse Colostomy for Refractory Hemorrhagic Chronic Radiation Proctitis With Moderate to Severe Anemia: a Prospective Cohort Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03397901
Enrollment
50
Registered
2018-01-12
Start date
2018-07-20
Completion date
2022-12-31
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia, Chronic Radiation Proctitis, Colostomy Stoma, Rectal Bleeding

Keywords

chronic radiation proctitis, rectal bleeding, transverse colostomy, refractory, moderate to severe anemia

Brief summary

Refractory rectal bleeding of chronic radiation proctitis (CRP) is still problematic and does not respond to medical treatments including reagents, endoscopic argon plasma coagulation (APC) or topical formalin. We proposed this prospective cohort study, to assess the efficacy and safety of colostomy in treating refractory hemorrhagic CRP with moderate to severe anemia, to provide higher-quality evidence of colostomy in these patients.

Detailed description

Chronic radiation proctitis (CRP) is a common complication after radiotherapy of pelvic malignancies, accounting for 5%-20% of cases. Rectal bleeding is the most common symptom, which accounts for \> 80% of CRP patients. Mild to moderate bleeding can be controlled by medical agents like sucralfate, endoscopic argon plasma coagulation (APC) or topical formalin. Severe and refractory bleeding is still problematic and refractory to these above medical treatments. Our previous retrospective study found that colostomy obtained a higher rate of bleeding remission (94% vs 12%) in 6 months, especially in control of transfusion-dependent bleeding (100% vs0%), when compared to conservative treatments.

Interventions

Transverse double-cavity colostomy

Sponsors

Sixth Affiliated Hospital, Sun Yat-sen University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Histologically diagnosed with pelvic malignancies, including gynecologic, prostate, or urinary cancers; * History of pelvic radiation; * No tumor recurrence or metastasis; * Refractory hemorrhagic CRP; * Time of rectal bleeding \>6 months; * SOBS=3 points; * severe anemia (Hb≤7 g/dl)or transfusion history for CRP bleedings.

Exclusion criteria

* Severe complications of CRP, including deep ulcer or fistula, stricture, necrosis, refractory perianal pain; * Other hemorrhagic diseases, like III-IV degree hemorrhoids; * History of colon or rectum resection; * Intestinal obstruction and surgery needed; * with contraindications to general anaesthesia (ASA class 4 or 5); * pregnant or breast-feeding; * history of mental disorder.

Design outcomes

Primary

MeasureTime frameDescription
remission rate of rectal bleeding after colostomy6 mon after colostomyretcal bleeding is assessed by soma scores

Secondary

MeasureTime frameDescription
Rate of colostomy closure1 years, 1.5 years, 2 yearsassess endoscopic findings before closure
Rate of severe CRP complications3 yearsinclude transfusion, deep ulceration or fistula, stricture, and refractory perianal pain
endoscopic score1 yearScore of Vienna Rectoscopy Score (VRS)
Remission rate of rectal bleeding1 year, 2years, 3 yearsretcal bleeding is assessed by soma scores
Anorectal function outcomesbaseline, 6 months, 1 year, 2 years, 3 yearsby Wexner score including 5 items: incontinence of solid stool, watery stool, gas, necessary of nursing pads, change of living habit
Rate of colostomy complicationsbaseline, 6 months, 1 year, 2 years, 3 yearssuch as prolapse, edema, necrosis, retraction.
Quality of life by EORTC scoresbaseline, 6 months, 1 year, 2 years, 3 yearsThe European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30),The EORTC QLQ-C30 is a 30-item questionnaire composed of multi-item scales and single items that reflect the multidimensionality of the quality-of-life construct. It incorporates five functional scales (physical, role, cognitive, emotional, and social), three symptom scales (fatigue, pain, and nausea and vomiting), and a global health and quality-of-life scale.

Countries

China

Contacts

Primary ContactLei Wang, Professor,MD
wangl9@mail.sysu.edu.cn00861392618055
Backup ContactZixu Yuan, MD,PhD
yuanzx@mail2.sysu.edu.cn008618820107381

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026